Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
Biochimica Et Biophysica Acta|June 13, 1991
Differential expression of the mouse alpha 1-acid glycoprotein genes (AGP-1 and AGP-2) during inflammation and agingK C Carter, D J Post, J PapaconstantinouAnnals of the New York Academy of Sciences|January 1, 1991
The effect of aging on constitutive mRNA levels and lipopolysaccharide inducibility of acute phase genesD J Post, K C Carter, J PapaconstantinouClinical and Diagnostic Laboratory Immunology|January 5, 1999
The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfectionK C Carter, A J Baillie, A B MullenThe Journal of Cell Biology|December 1, 1991
Discrete nuclear domains of poly(A) RNA and their relationship to the functional organization of the nucleusK C Carter, K L Taneja, J B LawrenceThe Journal of Biological Chemistry|March 5, 1989
Deadenylation of alpha 1-acid glycoprotein mRNA in cultured hepatic cells during stimulation by dexamethasoneK C Carter, S Bryan, P Gadson, et al.Antimicrobial Agents and Chemotherapy|October 23, 1997
Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasisA B Mullen, K C Carter, A J BaillieJournal of Drug Targeting|January 1, 1995
Visceral leishmaniasis in the BALB/c mouse: a comparison of the in vivo activity of five non-ionic surfactant vesicle preparations of sodium stibogluconateD M Williams, K C Carter, A J BaillieBiochemistry|April 16, 1991
Induction of several acute-phase protein genes by heavy metals: a new class of metal-responsive genesM Yiangou, X Ge, K C Carter, et al.Chromosoma|December 29, 1975
Chromosome distribution in neuroblast metaphase cells of Lucusta migratoria LD P Fox, T Mello-Sampayo, K C CarterAntimicrobial Agents and Chemotherapy|October 3, 1998
Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin BA B Mullen, A J Baillie, K C CarterPageof 11